View highlights and coverage from leading international congresses
touchIMMUNOLOGY joins Dr Birgit Weinberger (Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria) at EAACI 2021 to discuss the benefits and limitations of vaccinations in the older population. Questions 1. What is known about the severity of infection and immunogenicity of vaccines in older adults? (00:20-01:00) 2. What evidence supports the use of […]
It was a pleasure to meet with Prof. Andrea Rubbert-Roth (Kantonsspital St Gallen, St Gallen, Switzerland) to discuss the comparative efficacy of upadacitinib and abatacept in patients with rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs. The abstract ‘Clinical responses to upadacitinib or abatacept in patients with rheumatoid arthritis by type of prior biologic disease-modifying […]
Prof. Leon Kircik (Icahn School of Medicine at Mount Sinai, New York, NY, USA) kindly took the time to speak with us about the results from the recent phase 2b study investigating roflumilast foam in the treatment of scalp and body psoriasis. His abstract entitled ‘Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A […]
TouchIMMUNOLOGY caught up with Dr Emanuel Della Torre (Università Vita-Salute San Raffaele Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, Ospedale San Raffael, Milan, Italy) to discuss the current and future treatment of immunoglobulin G4-related (IgG4) diseases. His presentation entitled ‘Management: current therapy of IgG4-related systemic disease and what is on the horizon‘ was given […]
It was great to talk with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the current challenges and potential advances in treating Sjögren’s syndrome. Questions Why have so many clinical trials failed in primary Sjögren’s syndrome? (0:15) What are the hot topics and latest research you are looking forward to exploring in Sjögren’s syndrome […]
It was a delight to catch up with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the phase 2 study investigating subcutaneous belimumab and intravenous rituximab in primary Sjögren’s syndrome. The abstract ‘SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED […]
It was great to talk with Prof. Maarten Boers (VU University Medical Center, Amsterdam, The Netherlands) to discuss the responsiveness and high discriminative validity of GLOESS and clinical outcomes of synovitis in PsA patients treated with secukinumab from the ULTIMATE Trial. The abstract ‘Responsiveness of Ultrasound Synovitis and Clinical Outcomes in Psoriatic Arthritis Treated with […]
It was a pleasure to meet with Prof. Xenofon Baraliakos (Ruhr-University Bochum, Herne, Germany) to talk around his presentation on ‘Secukinumab in patients with psoriatic arthritis and axial manifestations: Predictors of response from the double-blind, randomised, phase 3b MAXIMISE trial.‘ (POS0930), which was presented at the European Congress of Rheumatology 2021, 2-5 June 2021. Questions […]
It was a pleasure to speak with Dr Esther van Zuuren (Leiden University Medical Centre, Leiden, the Netherlands) about current and emerging topical therapies in rosacea. Her presentation entitled ‘Update on topical drugs in rosacea‘ was received at the EADV Spring Symposium, 6-7 May 2021. Questions Could you give us an overview of the current […]
Get the latest clinical insights from touchIMMUNOLOGY
